Hybrid Treg cells: steel frames and plastic exteriors.
Sir William Dunn School of Pathology, University of Oxford, Oxford, UK.Nature Immunology (impact factor: 26.01). 07/2009; 10(6):563-4. DOI:10.1038/ni0609-563
Article: Transcription factors and th17 cell development in experimental autoimmune encephalomyelitis.Critical Reviews in Immunology 04/2013; 33(2):165. · 3.32 Impact Factor
Article: Transcription factors and th17 cell development in experimental autoimmune encephalomyelitis.[show abstract] [hide abstract]
ABSTRACT: Experimental autoimmune encephalomyelitis (EAE), a widely studied animal model of human central nervous system demyelinating diseases such as multiple sclerosis, is a T-cell-mediated autoimmune disease involving effector T helper (Th) subsets such as Th and Th7. Recently, Th7 cells have been shown to play a major role in many autoimmune and other inflammatory diseases. The development of Th subsets is controlled by a complex network of cytokines and signaling and transcription molecules that act to augment the development of one cell type while restricting the development of other lineages. Here, we review the transcription factors (TFs) that are required for Th17 cell development in EAE and classify them into three types: major or essential such as RORγt and STAT3, an array of helper factors that work in combination with or regulate the expression of the major factors, and regulatory TFs that attenuate the expression of Th17 genes. The plasticity of the Th17 cell lineage is also discussed in relation to the interaction of TFs that play a major role in the development of other Th or regulatory T cell (Treg) lineages such as T-bet and Foxp3 with the Th17 TFs.Critical Reviews in Immunology 01/2013; 33(2):165-82. · 3.32 Impact Factor
Dataset: Cancer Research 2009 Colombo
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.